# Passive Immunotherapy In Patients With SARS CoV-2

> **NCT05578391** · PHASE2 · COMPLETED · sponsor: **Fundacin Biomedica Galicia Sur** · enrollment: 61 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** Convalescent plasma

## Key facts

- **NCT ID:** NCT05578391
- **Lead sponsor:** Fundacin Biomedica Galicia Sur
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2022-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05578391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05578391, "Passive Immunotherapy In Patients With SARS CoV-2". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05578391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*